- Home
- SGLY vs BDRX Comparison
SGLY vs BDRX Comparison
Compare SGLY & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGLY
- BDRX
- Stock Information
- Founded
- SGLY 2001
- BDRX 2000
- Country
- SGLY United States
- BDRX United Kingdom
- Employees
- SGLY N/A
- BDRX N/A
- Industry
- SGLY
- BDRX Biotechnology: Pharmaceutical Preparations
- Sector
- SGLY
- BDRX Health Care
- Exchange
- SGLY Nasdaq
- BDRX Nasdaq
- Market Cap
- SGLY 4.1M
- BDRX 4.3M
- IPO Year
- SGLY 2008
- BDRX N/A
- Fundamental
- Price
- SGLY $0.93
- BDRX $7.24
- Analyst Decision
- SGLY
- BDRX
- Analyst Count
- SGLY 0
- BDRX 0
- Target Price
- SGLY N/A
- BDRX N/A
- AVG Volume (30 Days)
- SGLY 12.0K
- BDRX 34.9K
- Earning Date
- SGLY 08-26-2025
- BDRX 09-29-2025
- Dividend Yield
- SGLY N/A
- BDRX N/A
- EPS Growth
- SGLY N/A
- BDRX N/A
- EPS
- SGLY N/A
- BDRX N/A
- Revenue
- SGLY $2,172,036.00
- BDRX N/A
- Revenue This Year
- SGLY N/A
- BDRX N/A
- Revenue Next Year
- SGLY N/A
- BDRX N/A
- P/E Ratio
- SGLY N/A
- BDRX N/A
- Revenue Growth
- SGLY N/A
- BDRX N/A
- 52 Week Low
- SGLY $0.54
- BDRX $5.85
- 52 Week High
- SGLY $7.65
- BDRX $163.10
- Technical
- Relative Strength Index (RSI)
- SGLY 40.41
- BDRX 40.62
- Support Level
- SGLY $0.92
- BDRX $6.82
- Resistance Level
- SGLY $1.00
- BDRX $7.25
- Average True Range (ATR)
- SGLY 0.04
- BDRX 0.53
- MACD
- SGLY -0.00
- BDRX 0.06
- Stochastic Oscillator
- SGLY 11.11
- BDRX 47.90
About SGLY Singularity Future Technology Ltd.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.